Switch theme
Sign up to access all valuation multiples
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
2021
10.2K+
LTM Revenue $1.3B
LTM EBITDA $128M
$2.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
LifeStance Health has a last 12-month revenue (LTM) of $1.3B and a last 12-month EBITDA of $128M.
In the most recent fiscal year, LifeStance Health achieved revenue of $1.3B and an EBITDA of $39.9M.
LifeStance Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See LifeStance Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| Gross Profit | $423M | XXX | $402M | XXX | XXX | XXX |
| Gross Margin | 32% | XXX | 32% | XXX | XXX | XXX |
| EBITDA | $128M | XXX | $39.9M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 3% | XXX | XXX | XXX |
| EBIT | -$18.3M | XXX | -$31.6M | XXX | XXX | XXX |
| EBIT Margin | -1% | XXX | -3% | XXX | XXX | XXX |
| Net Profit | -$40.3M | XXX | -$57.4M | XXX | XXX | XXX |
| Net Margin | -3% | XXX | -5% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $132M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, LifeStance Health's stock price is $6.
LifeStance Health has current market cap of $2.3B, and EV of $2.6B.
See LifeStance Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.6B | $2.3B | XXX | XXX | XXX | XXX | $-0.11 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, LifeStance Health has market cap of $2.3B and EV of $2.6B.
LifeStance Health's trades at 2.1x EV/Revenue multiple, and 66.4x EV/EBITDA.
Equity research analysts estimate LifeStance Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
LifeStance Health has a P/E ratio of -57.3x.
See valuation multiples for LifeStance Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.3B | XXX | $2.3B | XXX | XXX | XXX |
| EV (current) | $2.6B | XXX | $2.6B | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | 20.7x | XXX | 66.4x | XXX | XXX | XXX |
| EV/EBIT | -144.8x | XXX | -83.8x | XXX | XXX | XXX |
| EV/Gross Profit | 6.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | -57.3x | XXX | -40.2x | XXX | XXX | XXX |
| EV/FCF | 35.5x | XXX | 30.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialLifeStance Health's last 12 month revenue growth is 13%
LifeStance Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $42K for the same period.
LifeStance Health's rule of 40 is 3% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
LifeStance Health's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for LifeStance Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Growth | 21% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 3% | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 43% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $42K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
LifeStance Health acquired XXX companies to date.
Last acquisition by LifeStance Health was XXXXXXXX, XXXXX XXXXX XXXXXX . LifeStance Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was LifeStance Health founded? | LifeStance Health was founded in 2021. |
| Where is LifeStance Health headquartered? | LifeStance Health is headquartered in United States of America. |
| How many employees does LifeStance Health have? | As of today, LifeStance Health has 10.2K+ employees. |
| Who is the CEO of LifeStance Health? | LifeStance Health's CEO is Mr. David P. Bourdon. |
| Is LifeStance Health publicy listed? | Yes, LifeStance Health is a public company listed on NAS. |
| What is the stock symbol of LifeStance Health? | LifeStance Health trades under LFST ticker. |
| When did LifeStance Health go public? | LifeStance Health went public in 2021. |
| Who are competitors of LifeStance Health? | Similar companies to LifeStance Health include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of LifeStance Health? | LifeStance Health's current market cap is $2.3B |
| What is the current revenue of LifeStance Health? | LifeStance Health's last 12 months revenue is $1.3B. |
| What is the current revenue growth of LifeStance Health? | LifeStance Health revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of LifeStance Health? | Current revenue multiple of LifeStance Health is 2.0x. |
| Is LifeStance Health profitable? | Yes, LifeStance Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of LifeStance Health? | LifeStance Health's last 12 months EBITDA is $128M. |
| What is LifeStance Health's EBITDA margin? | LifeStance Health's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of LifeStance Health? | Current EBITDA multiple of LifeStance Health is 20.7x. |
| What is the current FCF of LifeStance Health? | LifeStance Health's last 12 months FCF is $74.5M. |
| What is LifeStance Health's FCF margin? | LifeStance Health's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of LifeStance Health? | Current FCF multiple of LifeStance Health is 35.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
